Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.45 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.45 |
| ▸ | CXCL8 | P10145 | 5/20 | 0.41 |
| ▸ | F2R | P25116 | 2/20 | 0.41 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | CALCR | P30988 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30512658 | 0.85 | CXCL8 (0.44) | CXCL8CALCR | |
| SCHEMBL29855215 | 0.82 | BACE1 (0.41) | ACERENCALCR | |
| SCHEMBL29630344 | 0.82 | F2R (0.42) | F2RNAA50ACEREN | |
| SCHEMBL30434139 | 0.82 | ACE (0.54) | NMUR2F2RACEREN | |
| SCHEMBL29511796 | 0.82 | ACE (0.47) | CXCL8ACEREN | |
| SCHEMBL30434949 | 0.81 | ACE (0.55) | ACEREN | |
| SCHEMBL30987363 | 0.81 | NMUR2 (0.41) | NMUR2CXCL8 | |
| SCHEMBL1742627 | 0.81 | ACE (0.46) | ACEREN | |
| SCHEMBL1742626 | 0.81 | ACE (0.46) | ACEREN | |
| SCHEMBL30434874 | 0.80 | ACE (0.54) | F2RACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490215-A | Targeted mediated endocytic drug delivery | CRM医疗有限公司 | 2023-07-25 | — | — | CN | disclosed |